abagovomab 22
abciximab 23
abituzumab 20
abrilumab 18
actoxumab 11
adalimumab 16
aducanumab 8
afasevikumab 13
alacizumab_pegol 10
alemtuzumab 22
alirocumab 16
amatuximab 32
andecaliximab 18
anifrolumab 18
anrukinzumab 18
aprutumab 10
aprutumab_ixadotin 10
arcitumomab 20
ascrinvacumab 7
atezolizumab 15
atinumab 12
avelumab 13
basiliximab 23
bavituximab 30
begelomab 20
benralizumab 24
bevacizumab_beta 17
bezlotoxumab 11
bimagrumab 10
bleselumab 12
blinatumomab 28
blosozumab 27
bococizumab 14
brazikumab 11
brentuximab_vedotin 21
briakinumab 14
brodalumab 7
brolucizumab 22
brontictuzumab 21
burosumab 15
cabiralizumab 23
camrelizumab 11
canakinumab 20
cantuzumab_ravtansin 42
carlumab 12
carotuximab 21
cergutuzumab_amunaleukin2 22
cergutuzumab_amunaleukin 22
certolizumab_pegol 24
cetiximab 38
citatuzumab_bogatox 25
cixutumumab 19
clivatuzumab_tetraxetan 16
codrituzumab 28
conatumumab 6
concizumab 28
crenezumab 17
crizanlizumab 21
crotedumab 18
dacetuzumab 19
daclizumab 10
dalotuzumab 28
dapirolizumab_pegol 22
daratumumab 13
dectrekumab 8
demcizumab 19
denosumab 10
depatuxizumab 18
depatuxizumab_mafodotin 18
dezamizumab 18
dinutuximab 32
diridavumab 15
domagrozumab 13
drozitumab 12
duligotuzumab 18
durvalumab 4
dusigitumab 7
efalizumab 29
efungumab 26
eldelumab 10
elezanumab 14
elgemtumab 8
elotuzumab 11
emactuzumab 16
emapalumab 23
emibetuzumab 11
enavatuzumab 23
enfortumab_vedotin 10
enoblituzumab 16
enokizumab 19
enoticumab 14
ensituximab 26
eptinezumab 17
erenumab 15
etaracizumab 14
etrolizumab 21
evinacumab 21
evolocumab 7
farletuzumab 7
fasinumab 20
fezakinumab 13
fibatuzumab 6
ficlatuzumab 15
firivumab 31
flanvotumab 14
fletikumab 14
foralumab 9
foravirumab 12
fremanezumab 23
fresolimumab 17
fulranumab 19
futuximab 15
galcanezumab 15
ganitumab 25
gantenerumab 10
gemetuzumab 23
gemtuzumab2 24
gemtuzumab 18
gevokizumab 19
girentuximab 22
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 19
ibalizumab 24
ibritumomab 26
icrucumab 6
idarucizumab 27
ifabotuzumab 6
imalumab 16
imgatuzumab 16
inclacumab 11
indatuximab_ravtansin 24
indusatumab 9
inebilizumab 21
intetumumab 8
iodine_girentuximab 27
ipilimumab 3
iratumumab 6
isatuximab 31
itolizumab 22
ixekizumab 29
labetuzumab_govitecan 15
lambrolizumab 19
lampalizumab 20
lanadelumab 16
landogrozumab 16
laprituximab 21
lebrikizumab 33
lendalizumab 21
lenzilumab 12
lifastuzumab_vedotin 22
ligelizumab 19
lilotomab 32
lirilumab 15
lodelcizumab 15
lokivetmab 23
lorvotuzumab_mertansin 21
lucatumumab 26
lumretuzumab 13
lupartumab 7
lutikizumab 18
margetuximab 27
milatuzumab 31
mirvetuximab 26
mirvetuximab_soravtansin 26
modotuximab 30
mogamulizumab 27
monalizumab 16
motavizumab 24
moxetumomab_pasudotox 27
namilumab 12
naratuximab 22
naratuximab_emtansin 22
narnatumab 12
navicixizumab2 23
navicixizumab 22
navivumab 31
necitumumab 9
nemolizumab 22
nesvacumab 13
nivolumab 10
obiltoxaximab 19
obinutuzumab 33
ocaratuzumab 25
ofatumumab 13
olaratumab 16
olokizumab 24
omalizumab 19
onartuzumab 19
ontuxizumab 19
opicinumab 13
orticumab 9
otelixizumab 32
oxelumab 10
ozanezumab 25
pamrevlumab 9
panobacumab 20
parsatuzumab 21
pasotuxizumab 20
pateclizumab 14
patritumab 14
pembrolizumab 19
perakizumab 15
pidilizumab 16
pinatuzumab_vedotin 15
plozalizumab 26
pogalizumab 22
polatuzumab_vedotin 19
ponezumab 32
prezalumab 12
pritoxaximab 25
quilizumab 18
racotumomab 20
radretumab 14
ralpancizumab 19
ramucirumab 13
ranevetmab 18
ranibizumab 22
refanezumab 20
remtolumab 16
rilotumumab 10
rinucumab 17
risankizumab 32
rituximab 17
rivabazumab 13
robatumumab 20
roledumab 22
romosozumab 17
rontalizumab 19
rosmantuzumab 19
rozanolixizumab 17
sacituzumab 16
sacituzumab_govitecan 16
samalizumab 22
sapelizumab 22
sarilumab 11
secukinumab 8
seribantumab 15
setoxaximab 37
sifalimumab 7
siltuximab 23
simtuzumab 24
sirukumab 9
solanezumab 22
solitomab 18
stamulumab 14
suptavumab 15
suvizumab 14
tabalumab 8
tadocizumab 12
tamtuvetmab 29
tanezumab 21
tarextumab 7
tavolixizumab 17
telisotuzumab 25
teplizumab 15
tesidolumab 17
tezepelumab 20
tigatuzumab 16
tildrakizumab 18
timolumab 13
tisotumab 10
tosatoxumab 29
tositumomab 26
tralokinumab 20
trastuzumab 20
tregalizumab 23
trevogrumab 11
ublituximab 27
urelumab 13
ustekinumab 23
utomilumab 24
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 10
vantictumab 16
vanucizumab2 17
vanucizumab 23
varlilumab 12
vatelizumab 16
vedolizumab 18
veltuzumab 13
vesencumab 12
vorsetuzumab 17
vorsetuzumab_mafodotin 17
vunakizumab 27
xentuzumab 16
zatuximab 30
